| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |